Literature DB >> 12956903

Binding characteristics of fluoroquinolones to synthetic levodopa melanin.

Chiho Ono1, Makoto Tanaka.   

Abstract

To define the binding characteristics of fluoroquinolones to synthetic levodopa melanin, the binding of various drugs, including levofloxacin and ofloxacin, and positive controls (timolol and chloroquine), was investigated in-vitro. The affinity and capacity of the drug binding were calculated by Langmuir's adsorption isotherm. The affinity constant (K) and the binding capacity (r(max)) of levofloxacin were similar to those of timolol and much lower than those of chloroquine. Racemic ofloxacin and its enantiomers showed similar K and r(max), suggesting that the binding lacked stereoselectivity. The binding experiment with levofloxacin derivatives indicated that the basic nitrogen atom at position 7 of the quinolone ring, but not carboxyl group at position 3, would play a critical role in the interaction of fluoroquinolones with melanin. The melanin-drug complexes of levofloxacin and chloroquine were washed with neutral phosphate buffer, ethanol and 1 M HCl solution to explain the nature of the interaction of melanin with the drugs. Electrostatic forces mainly participate in the formation of the chloroquine-melanin complex, whereas van der Waals' and hydrophobic interactions are involved in the levofloxacin-melanin complex in addition to electrostatic forces. The interactions of various fluoroquinolones such as norfloxacin, enoxacin, sparfloxacin, ciprofloxacin and lomefloxacin with melanin were also studied. The results showed that the relative K value was: chloroquine approximately ciprofloxacin, sparfloxacin >/= lomefloxacin > timolol, levofloxacin approximately enoxacin, norfloxacin, and that the relative r(max) value was: norfloxacin, enoxacin >/= chloroquine, sparfloxacin > levofloxacin, ciprofloxacin, timolol, lomefloxacin. The fluoroquinolones vary in their affinity and capacity to bind with melanin, and ciprofloxacin and sparfloxacin showed a stronger interaction with melanin than the other fluoroquinolones studied.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956903     DOI: 10.1211/002235703322277168

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

Review 1.  Delivery of celecoxib for treating diseases of the eye: influence of pigment and diabetes.

Authors:  Aniruddha Amrite; Vidya Pugazhenthi; Narayan Cheruvu; Uday Kompella
Journal:  Expert Opin Drug Deliv       Date:  2010-05       Impact factor: 6.648

2.  The effect of ocular pigmentation on transscleral delivery of triamcinolone acetonide.

Authors:  Wennan Du; Shumao Sun; Yu Xu; Jie Li; Chunhui Zhao; Bifei Lan; Hao Chen; Lingyun Cheng
Journal:  J Ocul Pharmacol Ther       Date:  2013-04-18       Impact factor: 2.671

3.  Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrier.

Authors:  Rajendra S Kadam; Robert I Scheinman; Uday B Kompella
Journal:  Mol Pharm       Date:  2012-10-15       Impact factor: 4.939

4.  Effect of eye pigmentation on transscleral drug delivery.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

5.  Retinal safety of a new fluoroquinolone, pradofloxacin, in cats: assessment with electroretinography.

Authors:  Andre Messias; Florian Gekeler; Alfred Wegener; Klaus Dietz; Konrad Kohler; Eberhart Zrenner
Journal:  Doc Ophthalmol       Date:  2007-10-02       Impact factor: 2.379

6.  A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells.

Authors:  Yoo Chun Kim; Henry T Hsueh; Matthew D Shin; Cynthia A Berlinicke; Hyounkoo Han; Nicole M Anders; Avelina Hemingway; Kirby T Leo; Renee Ti Chou; HyeYoung Kwon; Matthew B Appell; Usha Rai; Patricia Kolodziejski; Charles Eberhart; Ian Pitha; Donald J Zack; Justin Hanes; Laura M Ensign
Journal:  Drug Deliv Transl Res       Date:  2021-04-26       Impact factor: 4.617

7.  Effect of norfloxacin and moxifloxacin on melanin synthesis and antioxidant enzymes activity in normal human melanocytes.

Authors:  Artur Beberok; Dorota Wrześniok; Michał Otręba; Maciej Miliński; Jakub Rok; Ewa Buszman
Journal:  Mol Cell Biochem       Date:  2014-11-30       Impact factor: 3.396

8.  Local drug delivery using poly(lactic-co-glycolic acid) nanoparticles in thermosensitive gels for inner ear disease treatment.

Authors:  Dong-Hyun Kim; Thu Nhan Nguyen; Young-Min Han; Phuong Tran; Jinhyung Rho; Jae-Young Lee; Hwa-Young Son; Jeong-Sook Park
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

9.  Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies.

Authors:  R L Schroeder; J P Gerber
Journal:  Toxicol Rep       Date:  2014-11-04

10.  Lomefloxacin Induces Oxidative Stress and Apoptosis in COLO829 Melanoma Cells.

Authors:  Artur Beberok; Dorota Wrześniok; Martyna Szlachta; Jakub Rok; Zuzanna Rzepka; Michalina Respondek; Ewa Buszman
Journal:  Int J Mol Sci       Date:  2017-10-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.